Merck & Co., Inc. (NYSE:MRK) Receives $117.12 Average Price Target from Brokerages
Merck & Co., Inc. (NYSE:MRK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the firm, MarketBeat reports. Eleven research analysts have rated the stock with a hold rating, nine have assigned a buy rating and three have given a strong buy rating to […]
Merck & Co., Inc. (NYSE:MRK – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are currently covering the firm, MarketBeat reports. Eleven research analysts have rated the stock with a hold rating, nine have assigned a buy rating and three have given a strong buy rating to […]
